Join SGS at the 3rd Annual Cell & Gene Therapy Innovation Leaders Summit - February 5-6, 2020 in Berlin, Germany - and find out more about our biosafety solutions.
The Global Cell and Gene Therapy Market is estimated to be worth between £10 to £40 Billion by 2025.
The Annual Cell and Gene Therapy Innovation Summit is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell and Gene Therapy area.
The program covers critical subjects, such as progress cell gene therapy manufacturing, ATMP development, scale-up and scale-out, manufacturing data, research and development, CAR-T therapies, global regulatory affairs, stem cells and cord blood. It also explores pricing, reimbursement, improving cost efficiency, commercialization, and how to leverage innovation to convert cutting-edge research and advance cell gene therapy manufacturing.
Join our team in Berlin to discover our biosafety services and how we can help get your product to market quickly and efficiently.
For further information, please contact:
Josee Leach
Global Marketing Manager, Life Sciences
SGS
t: +44 7889 939 512
www.sgs.com/en/life-sciences